NEW YORK (GenomeWeb) – Illumina reported after the close of the market today that total fourth quarter 2014 revenues increased 32 percent year over year.

The San Diego-based company said that for the last three months of 2014, it took in $512.4 million in total revenues, up from $387.3 in the year ago quarter. Product revenues climbed 34 percent in the quarter to $450.3 million from $336.4 million in Q4 2013, while service revenue grew 22 percent to $62.1 million from $50.9 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers are refining a tool to predict a woman's risk of developing breast cancer, according to the Guardian.

According to Stat News, the partial government shutdown in the US could soon affect the ability of the Food and Drug Administration to review new drugs.

In PNAS this week: gypsy moth genome sequenced, phylogenomic analysis of Polyneopterans, and more.

CNN reports that people's genes tend to have a greater influence on their risk of developing disease than their environment, but it varies by phenotype.